These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 28049176)

  • 1. Applicability of the World Health Organization recommended new shorter regimen in a multidrug-resistant tuberculosis high burden country.
    Javaid A; Ahmad N; Khan AH; Shaheen Z
    Eur Respir J; 2017 Jan; 49(1):. PubMed ID: 28049176
    [No Abstract]   [Full Text] [Related]  

  • 2. Tuberculosis treatment: dangerous regimens?
    Rieder HL; Arnadottir T; Trébucq A; Enarson DA
    Int J Tuberc Lung Dis; 2001 Jan; 5(1):1-3. PubMed ID: 11263509
    [No Abstract]   [Full Text] [Related]  

  • 3. Proposal for a standardised treatment regimen to manage pre- and extensively drug-resistant tuberculosis cases.
    Caminero JA; Piubello A; Scardigli A; Migliori GB
    Eur Respir J; 2017 Jul; 50(1):. PubMed ID: 28679614
    [No Abstract]   [Full Text] [Related]  

  • 4. Is the treatment of WHO category I tuberculosis with 2HRZE/6HE a defensible practice?
    Long R; Scalcini M
    Int J Tuberc Lung Dis; 1999 Sep; 3(9):747-8. PubMed ID: 10488879
    [No Abstract]   [Full Text] [Related]  

  • 5. Results of a 12-month regimen for drug-resistant pulmonary tuberculosis.
    Pérez-Guzmán C; Vargas MH; Martínez-Rossier LA; Torres-Cruz A; Villarreal-Velarde H
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1102-9. PubMed ID: 12546119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The combination of amoxicillin-clavulanic acid and ofloxacin in the treatment of multidrug-resistant Mycobacterium tuberculosis].
    Iwanaga T; Yokota K; Kishikawa R; Ikeda T; Tsurutani H; Hirose T; Nishima S
    Kekkaku; 1997 Jan; 72(1):9-13. PubMed ID: 9038010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society.
    Monaldi Arch Chest Dis; 1994 Sep; 49(4):327-45. PubMed ID: 8000420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapy of tuberculosis in the adult].
    Schrappe M; Wassermann K; Kroegel C
    Med Klin (Munich); 1995 Apr; 90(4):229-30. PubMed ID: 7776936
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effectiveness and problems of PZA-containing 6-month regimen for the treatment of new pulmonary tuberculosis patients].
    Wada M
    Kekkaku; 2001 Jan; 76(1):33-43. PubMed ID: 11211781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applicability of the shorter 'Bangladesh regimen' in high multidrug-resistant tuberculosis settings.
    Sotgiu G; Tiberi S; Centis R; D'Ambrosio L; Fuentes Z; Zumla A; Migliori GB
    Int J Infect Dis; 2017 Mar; 56():190-193. PubMed ID: 27816662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Short-course chemotherapy of tuberculosis with pyrazinamide].
    Asai S; Futsuki Y; Tomari S; Araki J
    Nihon Rinsho; 1998 Dec; 56(12):3087-90. PubMed ID: 9883615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency of recurrence among MDR-tB cases 'successfully' treated with standardised short-course chemotherapy.
    Migliori GB; Espinal M; Danilova ID; Punga VV; Grzemska M; Raviglione MC
    Int J Tuberc Lung Dis; 2002 Oct; 6(10):858-64. PubMed ID: 12365571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Additional evidence to support the phasing-out of treatment category II regimen for pulmonary tuberculosis in Peru.
    Ponce M; Ugarte-Gil C; Zamudio C; Krapp F; Gotuzzo E; Seas C
    Trans R Soc Trop Med Hyg; 2012 Aug; 106(8):508-10. PubMed ID: 22742941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High hepatotoxicity of pyrazinamide and ethambutol for treatment of latent tuberculosis.
    Younossian AB; Rochat T; Ketterer JP; Wacker J; Janssens JP
    Eur Respir J; 2005 Sep; 26(3):462-4. PubMed ID: 16135729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Short-course treatment of pulmonary tuberculosis: comparison with a classical standard regimen].
    Bouslama A; Hedhiri H; Marzouki M; Jerray M; Djenayah F
    Bull Int Union Tuberc; 1985; 60(1-2):29-30. PubMed ID: 4074969
    [No Abstract]   [Full Text] [Related]  

  • 16. Two excellent management tools for national tuberculosis programmes: history of prior treatment and sputum status at two months.
    Trébucq A; Rieder HL
    Int J Tuberc Lung Dis; 1998 Mar; 2(3):184-6. PubMed ID: 9526189
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment outcome of patients with multidrug-resistant pulmonary tuberculosis during pregnancy].
    Takashima T; Danno K; Tamura Y; Nagai T; Matsumoto T; Han Y; Ano H; Yoshida H; Kawahara K; Tsuyuguchi I
    Kekkaku; 2006 Jun; 81(6):413-8. PubMed ID: 16838679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled trial of 6-month and 8-month regimens in the treatment of pulmonary tuberculosis. First report.
    Am Rev Respir Dis; 1978 Aug; 118(2):219-28. PubMed ID: 100029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-administered, standardized regimens for multidrug-resistant tuberculosis in South Korea.
    Park SK; Lee WC; Lee DH; Mitnick CD; Han L; Seung KJ
    Int J Tuberc Lung Dis; 2004 Mar; 8(3):361-8. PubMed ID: 15139476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multidrug-resistant TB in Eastern region of the EU: is the shorter regimen an exception or a rule?
    Balabanova Y; Fiebig L; Ignatyeva O; Riekstina V; Danilovits M; Jaama K; Davidaviciene E; Radiulyte B; Popa CM; Nikolayevskyy V; Drobniewski F
    Thorax; 2017 Sep; 72(9):850-852. PubMed ID: 28209653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.